Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.
作者:
主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);队列研究(Cohort Studies);核心结合因子类(Core Binding Factors);阿糖胞苷(Cytarabine);柔红霉素(Daunorubicin);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);缓解诱导(Remission Induction);干细胞移植(Stem Cell Transplantation);存活率(Survival Rate);青年人(Young Adult)
DOI
10.1093/jjco/hyq007
PMID
20185460
发布时间
2013-11-21
- 浏览32
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文